Evaluation of the management and follow-up of diabetic patients in the prevention of diabetic retinopathy
e202404030
Keywords:
Diabetic Retinopathy, Diabetes Mellitus, Health care quality indicators, Teleophthalmology, Ophthalmological diagnostic techniques, Primary Health Care, Access and evaluationAbstract
BACKGROUND // Diabetes mellitus is a chronic disease with high morbidity and mortality, affecting 537 million adults worldwide. Spain is the second European country in prevalence, with 14.8% in the population aged twenty/seventy-nine years; with 11.6 cases per 1,000 people/year. Diabetic retinopathy (DR) is the fifth cause of vision loss worldwide and the seventh cause of blindness/visual impairment among members of the National Organization of the Blind in Spain (ONCE). Early detection of DR prevents blindness in diabetics and is conditioned by glycosylated hemoglobin. The aim of this paper was to analyze the management of diabetic patients in Aljarafe region (Seville) and identify opportunities for improvement in the coordination of their follow-up between the Primary Care physician and the ophthalmologist.
METHODS // A retrospective observational study (2016-2019) was carried out, with patients registered in the diabetic census of the twenty-eight municipalities of Aljarafe. The primary care and hospital health history, and telemedicine program were consulted. About statistical analysis, for qualitative variables, totals and percentages were calculated; for quantitative variables, mean and standard deviation (if normally distributed) and median and quartiles (if non-normally distributed).
RESULTS // There were 17,175 diabetics registered in Aljarafe (5.7% of the population); 14,440 patients (84.1%) had some determination of hemoglobin during the period, 9,228 (63.9%) had all of them in the appropriate range. Fundoscopic control was performed on 12,040 diabetics (70.1%), and of those who did not, 346 (10.6%) had all of them out of range. There were 1,878 (10.9%) patients without fundoscopic or metabolic control, 1,019 (54.3%) were women, 1,219 (64.9%) were under sixty-five years of age, 1,019 (54.3%) had severe comorbidity.
CONCLUSIONS // Most patients have adequate screening, and more than half have determinations within range. However, a significant percentage with no glycated hemoglobin within range lack fundoscopic control, and another smaller group lack fundoscopic or metabolic control, with inter-municipal variability. We propose to improve communication channels between levels.
Downloads
References
Romero-Aroca P, López-Galvez M, Martinez-Brocca MA, Pareja-Ríos A, Artola S, Franch-Nadal J et al. Changes in the Epidemiology of Diabetic Retinopathy in Spain: A Systematic Review and Meta-Analysis. Healthcare. 2022 Jul 16;10(7):1318.
Federación Internacional de Diabetes. Atlas de diabetes de la FID. 10ª edición. Bruselas, Bélgica; 2021.
Rojo-Martínez G, Valdés S, Soriguer F, Vendrell J, Urrutia I, Pérez V et al. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study. Sci Rep. 2020 Jun;10(1):2765.
Martínez Brocca M, Aguilar Diosdado M, Candela Gómez C, Cornejo Castillo M, Fernández Oropesa C, Galán Retamal C. Diabetes mellitus. Proceso asistencial integrado. [Internet]. 3ª edición. 2018. Junta de Andalucía. Consejería de Salud., editor. Sevilla; [consultado 5 jun 2023]. Disponible en: https://www.juntadeandalucia.es/export/drupaljda/diabetes_mellitus_2018_18_06_2018.pdf
Bourne RRA, Jonas JB, Bron AM, Cicinelli M V, Dans A, Flaxman MR. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, time trends, and projections. Fr J Oftalm. 2018;102:575-585.
Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Jun;9(2):e144-160.
ONCE. Servicios sociales para personas afiliadas. Memoria de actuación 2021. Anexo al acuerdo 3/2022-2.3, de 29 de junio 2022.
Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabetic Medicine. 2010 Jun;27(3):249-256.
American Diabetes Association. Section 12, Retinopathy, Neuropathy, and Foot Care: Standards of Diabetes Care. Diabetes Care. 2022;45:S185-194.
Piñas García P, Hernández Martínez FJ, Aznárez López N, Castillón Torre L, Tena Sempere ME. Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study. Antioxidants. 2022 Jun;11(1):116.
Ministerio de Sanidad Servicios Sociales e Igualdad. Estrategia en Diabetes del Sistema Nacional de Salud: Actualización [Internet]. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2012 [consultado 7 jun 2023]. Disponible en: https://www.sanidad.gob.es/organizacion/sns/planCalidadSNS/pdf/excelencia/cuidadospaliativos-diabetes/DIABETES/Estrategia_en_diabetes_del_SNS_Accesible.pdf
Sociedad Española de Retina y Vítreo. Manejo de las complicaciones oculares de la diabetes. Retinopatía Diabética y Edema Macular. “Guías de Práctica Clínica de la SERV”. [Internet]. 2009 [consultado 7 jun 2023]. Disponible en: https://serv.es/wp-content/pdf/guias/Guia_SERV_03_terceraRevision.pdf
García Soidán J. Guía de diabetes tipo 2 para clínicos: Recomendaciones de la redGDPS. Fundación redGPDS, editor. España; 2018.
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018 Jun;17(1):83.
Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021 Jun;78(5):1197-1205.
Song A, Lusk JB, Roh KM, Jackson KJ, Scherr KA, McNabb RP et al. Practice Patterns of Fundoscopic Examination for Diabetic Retinopathy Screening in Primary Care. JAMA Netw Open. 2022 Jun 27;5(6):e2218753.
Daskivich LP, Vasquez C, Martinez C, Tseng CH, Mangione CM. Implementation and Evaluation of a Large-Scale Teleretinal Diabetic Retinopathy Screening Program in the Los Angeles County Department of Health Services. JAMA Intern Med. 2017 Jun;177(5):642.
Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017 Jun;54(6):515-525.
Martínez MA, Mayoral E, Irastorza A, Lama C, Martínez E, Sanz R. Plan Integral de Diabetes de Andalucía: Actualización 2016. Junta de Andalucía, Consejería de Salud; 2016.
Downloads
Additional Files
Published
Versions
- 2024-04-10 (3)
- 2024-04-10 (2)
- 2024-04-10 (1)
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Purificación Piñas García, María Victoria Ruíz Romero, Luis Gabriel Luque Romero, Carlos Alberto Gómez Jiménez, Luis Castillón Torre, Francisco Javier Hernández Martínez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.